Money should help develop treatment that breaks transmission cycles of elephantiasis and river blindness
Japan’s Global Health Innovative Technology Fund announced it is investing 790 million yen (US$5.3 million) into researching two neglected tropical diseases: lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness).
The funds will be used to develop new drugs for the diseases, which are caused by parasitic infection. “Even in the midst of a pandemic, GHIT Fund is committed to advancing product development to contribute to global health,” said Osamu Kunii, the fund’s CEO, in a statement on 11 November.